Medical Toxicology and Applied Pharmacology

Siniša Franjić lives in Osijek, Croatia. Primary and two secondary schools ended in Osijek and graduated from the Faculty of Law of the University of Split. Thesis entitled "Legal aspects of information systems" was defended by Summa Cum Laude and he becomes LLM of Law. Since 1992., he works as a journalist - freelance contributor to the first Radio Osijek of HRT (Croatian Radio Television), and then something shorter, among other media, he works for HTV - TV centre Osijek, weekly "Školske novine (School Newspaper)“ and the monthly "Super Kino Video (Super Cinema video)". In the academic year 2009./2010., Faculty of Electrical Engineering in Osijek (today Faculty of Electrical Engineering, Computer Science and Information Technology Osijek) was appointed as a part-time assistant on the course "Computer criminality". With Computer criminality, he is studying Medical law and a few other legal disciplines. In the Faculty of Electrical Engineering in Osijek, he participated in the teaching the courses "Computer criminality" and "Legal regulations in electrical engineering and computer science" and in the Faculty of Medicine in Osijek, he participated in the teaching the courses "Social and health legislation" and "Medicine and Health Law". The successful defence of the doctoral dissertation on the topic from Criminal law called "The Criminal justice and forensic aspects of computer criminality", he received a PhD degree from the Faculty of Law of the International University of Brčko District in Brčko, Bosnia and Herzegovina. He is the author of several books and many scientific papers. He actively participates in a few journals like reviewer and Editorial Board member and member of Organizing Committees in few international scientific conferences.

Pharmacy, Genetics, Pharmacogenetics, Drugs, Medicine

Dr. Rajendra K. Singh has been working as a Molecular Toxicologist and Biocompatibility Subject Matter Specialist in academics and industry set up for over 18 years and his career includes numerous citations for excellence in leadership relating to health and biological safety assessments of industrial chemicals, medical devices, and drug-device combination products. Rajendra Singh is currently serving as a manuscript reviewer for more than 20 Journals including, Cancer Research, and Clinical Cancer Research. He is an editorial board member for the Journal of Cancer Science and Therapy, Medical and Surgical Urology, and is affiliated with several professional societies, including the Society of Toxicology, and the American Association for Cancer Research. He is the founder of the USHA foundation a non-Profit organization developing health awareness and learning tools projects.

Biocompatibility/ toxicological assessment of medical devices, biocompatibility assessment of drugs devices combination products, medical device testing and biological risk assessment.

Dr Idowu E.O, a 35-year-old scholar from College of Medicine, University of Ibadan. He is the director of Dr Peak Specialist Hospital and founder of Dr Emmanuel International Medical Foundation, a philanthropic organization. He has papers in reputed literary archives and currently serves as an organizing committee member of repute for international conferences.. (Up to 100 words)

Road traffic injury, Neuro-toxicology, codeine+tramadol, Neurotropic substances

Asif Mahmood, M.D., M.P.H., M.B.A., has served as our Chief Safety Officer/Vice President of Global Safety & Pharmacovigilance since July 2019. Prior to joining Medicago, Asif Mahmood held several roles of increasing responsibility from Director to Associate Vice President at Pfizer, Sanofi, Genzyme, Sanofi Pasteur and Apotex in the US and Canada from 2004 to 2019. He has experience in working in many diverse therapeutic areas including Vaccines, hepatology, oncology, infectious diseases, rare diseases, biosimilars, drug delivery devices, generics, and OTC. Earlier in his career, he served as the Deputy Director-General, Federal Ministry of Health in Islamabad, Pakistan, and as Medical Director and Joint Executive Director for Pakistan Institute of Medical Sciences and Children's hospital Islamabad. He has also served on many public health and immunization projects of WHO, UNICEF and the Japan International Corporation Agency. He received his M.D., from King Edwards Medical University in Pakistan, in addition to completing M.P.H and M.B.A.

Global Safety & Pharmacovigilance

Dr. Dafny received his M.S. and Ph.D. degrees from Hadassah Medical School in Jerusalem in 1965 and 1969, respectively followed by post-docs at Caltech, UCLA, and Columbia. He is currently a professor of Neurobiology at the University of Texas Medical School at Houston. The main focus of his research is on two topics: pain mechanisms, including pain suppression and electro-acupuncture, and drug abuse mechanisms, involving morphine, cocaine, alcohol, Ritalin, ecstasy, and Prozac. Behavioural, neurophysiological, pharmacological, endocrinological, and immunological procedures are used, primarily with the rodent as an animal model. The electrophysiological procedures used include single cell and evoked potential recording, electroencephalography (EEG), and brain stimulation. Computerized techniques are used for monitoring animal behaviour. He is also involved with several other studies. These concern connections between the nervous, immune, and endocrine systems; brain regulation of hormonal secretion; mechanisms of obesity and satiety; and the electrophysiology of neurotransmitters such as dopamine, serotonin, norepinephrine, and peptides, with clinical application to Parkinsonism, Huntington's chorea, and Tardive dyskinesia. In addition, collaborative immunological and endocrinologic studies are conducted with other groups in the Texas Medical Center. Dr Dafny is a member of several professional organizations including the Society for Neuroscience, Society for Experimental Biology and Medicine, the New York Academy of Sciences, the American Society for Pharmacology and Experimental Therapeutics, and the American Physiological Society, among others.

Pain suppression and electro-acupuncture, and drug abuse mechanisms

Stef Stienstra works internationally for several medical and biotech companies as Scientific Advisory Board Member and is also an active reserve officer of the Royal Dutch Navy in his rank as Commander (OF4). For the Dutch Armed Forces, he is a CBRNe specialist with a focus on (micro)biological and chemical threats and a medical and environmental functional specialist within the 1st CMI (Civil-Military Interaction) Battalion of the Dutch Armed Forces. For Expertise France he is now managing an EU CBRN CoE public health project in West Africa. He is visiting Professor at the University of Rome Tor Vergata giving lectures for the CBRN Master's study. He has finished both his studies in Medicine and in Biochemistry in The Netherlands with a doctorate and has extensive practical experience in cell biology, immuno-haematology, infectious diseases, biodefense and transfusion medicine. His natural business acumen and negotiation competence help to initiate new successful businesses, often generated from unexpected combinations of technologies.

CBRN, SARS-COV 2, BIO-WEAPON